CGEM
Cullinan Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$15.45
−0.71%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-63.6%
Return on equity
-56.3%
Return on assets
-68.5%
Return on invested capital
0.00x
Asset turnover
-$159.3M
Cash from operations
$5.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026